Ibethelwa liza lesihlanu lesixeko se-COVID-19, iHong Kong ijongene nexesha layo lezempilo elibi ukusukela oko ubhubhane waqala kwiminyaka emibini eyadlulayo.Inyanzelise urhulumente wesixeko ukuba aphumeze amanyathelo angqongqo, kubandakanya novavanyo olunyanzelekileyo kubo bonke abahlali baseHong Kong.
NgoFebruwari ubone amawaka amatyala amatsha, ubukhulu becala ukusuka kukwahluka kwe-omicron.Umahluko we-Omicron usasazeka ngokulula kunentsholongwane yokuqala ebangela i-COVID-19 kunye nokwahluka kweDelta.I-CDC yayilindele ukuba nabani na onosulelo lwe-Omicron angasasaza intsholongwane kwabanye, nokuba ugonyiwe okanye akanazimpawu.
Ngokwezibalo ezihlaziyiweyo, iimeko ze-29272 ezongezelelweyo eziqinisekisiweyo zabikwa ngo-Matshi 16 ukusuka kwiZiko loKhuseleko lwezeMpilo (CHP) lweSebe lezeMpilo (DH), eHong Kong.Ngenxa yamatyala amaninzi aqinisekisiweyo yonke imihla, igagasi lamva nje losulelo lwe-COVID-19 "luyoyike" iHong Kong, inkokeli yesixeko yazisola ukutsho.Izibhedlele zazinqongophele ziibhedi yaye kunzima ukujamelana nazo, yaye abantu baseHongkong babetyhwatyhwa luloyiko.Ukunciphisa iimeko eziqinisekisiweyo kunye nokunciphisa uxinzelelo, inani elikhulu leekhithi zovavanyo zafuneka ukwenza uhlolo olukhulu.Nangona kunjalo, ngenxa yokunyuka kweemfuno, kwakungekho mpahla yaneleyo kwisitokhwe.Emva kokufunda ngale meko, i-Bioantibody Biotechnology Co., Ltd. (i-Bioantibody) yangena ngokukhawuleza kwimeko "yokulungiselela imfazwe".Abantu be-Bioantibody basebenze nzima ukuvelisa izixhobo eziphambili kunye nezixhobo zovavanyo ezikhawulezayo ze-SARS-CoV-2 antigen.Kunye neearhente zikarhulumente kunye nombutho waphesheya waseTshayina ovela eYixing naseShanwei, iBioantibody yazisa inani elikhulu leekhithi eHong Kong.U-Bioantibody unqwenelele ukuba ezi zixhobo zingenza igalelo ekusombululeni iimfuno ezingxamisekileyo zabantu baseHong Kong kwaye benze oko i-Bioantibody inokukwenza kuthintelo lobhubhane.
I-Bioantibody SARS-CoV-2 Antigen Rapid Test Kit yamkelwe yiManyano yaseYurophu nakuluhlu lwamazwe aliqela, anje ngeBundesinstitut für Arzneimittel und Medizinprodukte, (BfArM, Germany) , MINISTÈRE DES SOLIDARITÉS: ET DE LA SANTÉ (France), I-COVID-19 kwiVitro Diagnostic Devices and Test Methods Database (IVDD-TMD), njalo njalo.